DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Xofigo

Topstories

The Future Lies in the Genome

07.10.2015 - Kemal Malik, board member for innovation at the German Bayer Group, sees many similarities in the genetic system of humans, animals and plants. This opens the door for synergies in...

News

Bayer Has “Great Plans” for Life Sciences, CEO Says

12.03.2015 - Bayer aims to achieve strong sales and earnings growth for its life science businesses in the coming years, CEO Marijn Dekkers said at the "Meet Management" investor conference in...

News

Bayer Buoyed by Health and Agriculture in Q3

31.10.2014 - Buoyed by a strong performance in its Healthcare and CropScience businesses in the third quarter, Bayer has raised its forecast for full year 2014. CEO Marijn Dekkers said he...

News

Bayer Launches Takeover Offer for Algeta

21.01.2014 - Bayer Nordic, based at Espoo, Finland, has launched a takeover vehicle for the acquisition of Norwegian pharmaceutical producer Algeta. Through the subsidiary, the Bayer group has...

News

Bayer Confirms €42.80 per Share Bid for Algeta

30.12.2013 - Germany's Bayer finally confirmed its plans to acquire Norwegian pharmaceutical company Algeta shortly before Christmas. The German chemicals and pharmaceuticals group said Algeta...

News

Bayer Preparing A Bid For Norwegian Drug Partner Algeta

26.11.2013 - German pharmaceutical group Bayer is preparing a bid to acquire Algeta, its partner for its prostate cancer treatment Xofigo, a German newspaper reported on Tuesday. The...

News

Bayer Expects to Meet Earnings Forecast Despite Polymer Woes

05.11.2013 - With three quarters of 2013 behind it, Germany's Bayer group sees itself as still on track to fulfil the "ambitious forecast" for 2013 voiced by CEO Marijn Dekkers earlier this...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.